Literature DB >> 10103221

Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus.

J E Gustafson1, P V Candelaria, S A Fisher, J P Goodridge, T M Lichocik, T M McWilliams, C T Price, F G O'Brien, W B Grubb.   

Abstract

Salicylate and acetylsalicylate slightly increased fluoroquinolone resistance in ciprofloxacin-susceptible and -resistant Staphylococcus aureus. Salicylate allowed a greater number of cells from ciprofloxacin-susceptible and -resistant strains to survive on high fluoroquinolone concentrations. Salicylate also increased the frequency with which a susceptible strain mutated to become more resistant to ciprofloxacin.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10103221      PMCID： PMC89247     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

Review 2.  Methicillin-resistant staphylococci.

Authors:  H F Chambers
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants.

Authors:  H Okusu; D Ma; H Nikaido
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

4.  Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis.

Authors:  Y Sumita; M Fukasawa
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

5.  Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.

Authors:  E Y Ng; M Trucksis; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

6.  Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.

Authors:  E Y Ng; M Trucksis; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.

Authors:  L Ferrero; B Cameron; B Manse; D Lagneaux; J Crouzet; A Famechon; F Blanche
Journal:  Mol Microbiol       Date:  1994-08       Impact factor: 3.501

8.  Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein.

Authors:  J L Burns; D K Clark
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

9.  Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli.

Authors:  S P Cohen; H Hächler; S B Levy
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

10.  Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.

Authors:  H Ito; H Yoshida; M Bogaki-Shonai; T Niga; H Hattori; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191
View more
  17 in total

1.  Fusidic acid monotherapy.

Authors:  V Vassiliou; A K Demetriades; G Scott
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 5.344

2.  Presence of multidrug-resistant enteric bacteria in dairy farm topsoil.

Authors:  J M Burgos; B A Ellington; M F Varela
Journal:  J Dairy Sci       Date:  2005-04       Impact factor: 4.034

3.  Contributions of sigB and sarA to distinct multiple antimicrobial resistance mechanisms of Staphylococcus aureus.

Authors:  James T Riordan; Jessica O O'Leary; John E Gustafson
Journal:  Int J Antimicrob Agents       Date:  2006-06-14       Impact factor: 5.283

Review 4.  Antimicrobial Effects of Antipyretics.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

5.  Response of Staphylococcus aureus to salicylate challenge.

Authors:  James T Riordan; Arunachalam Muthaiyan; Wayne Van Voorhies; Christopher T Price; James E Graham; Brian J Wilkinson; John E Gustafson
Journal:  J Bacteriol       Date:  2006-10-20       Impact factor: 3.490

6.  Targeting MgrA-mediated virulence regulation in Staphylococcus aureus.

Authors:  Fei Sun; Lu Zhou; Bing-Chuan Zhao; Xin Deng; Hoonsik Cho; Chengqi Yi; Xing Jian; Chun-Xiao Song; Chi-Hao Luan; Taeok Bae; Zigang Li; Chuan He
Journal:  Chem Biol       Date:  2011-08-26

7.  Multiple antibiotic resistance (mar) locus in Salmonella enterica serovar typhimurium DT104.

Authors:  L P Randall; M J Woodward
Journal:  Appl Environ Microbiol       Date:  2001-03       Impact factor: 4.792

8.  Salicylate reduces susceptibility of Mycobacterium tuberculosis to multiple antituberculosis drugs.

Authors:  Alain Schaller; Zhonghe Sun; Yongping Yang; Akos Somoskovi; Ying Zhang
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Salicylic acid diminishes Staphylococcus aureus capsular polysaccharide type 5 expression.

Authors:  Lucía P Alvarez; María S Barbagelata; Mariana Gordiola; Ambrose L Cheung; Daniel O Sordelli; Fernanda R Buzzola
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

10.  Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus.

Authors:  Leon Iri Kupferwasser; Michael R Yeaman; Cynthia C Nast; Deborah Kupferwasser; Yan-Qiong Xiong; Marco Palma; Ambrose L Cheung; Arnold S Bayer
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.